Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SNGX Soligenix, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.36 -2.2% | $16.31 +6.3% |
| StockIQ Score | 41D Weak Risk: Medium | 42D Weak Risk: Medium |
| Technical | 13F | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 52C- | 50C- |
| Fair Value | 55C | 38F |
| News | 56C | 50C- |
| Quality | 42D | 50C- |
| Risk | 48D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Soligenix (SNGX) scores higher in fundamentals (46 vs. 35) and valuation (55 vs. 38), showing stronger stability and perceived market value. Ascentage Pharma (AAPG) leads slightly in growth (50 vs. 52, but closer) and investor sentiment (42 vs. 41), though both have weak overall ratings. SNGX’s technical score (13 vs. 36) is weaker, indicating less short-term momentum.
